THE USE OF HALLUCINOGENS IN THE TREATMENT OF ADDICTION
Guardado en:
HALPERN, J.H., THE USE OF HALLUCINOGENS IN THE TREATMENT OF ADDICTION. ADDICTION RESEARCH, Vol. 4, no. 2 (1996), p. 177-189.
Ref.
52303
Localización:
SIIS R.1038
Palabras clave:
Alucinógenos, Drogodependencias, Fármacos, LSD, Tratamiento médico
Alucinógenos, Drogodependencias, Fármacos, LSD, Tratamiento médico
Ejemplares similares: THE USE OF HALLUCINOGENS IN THE TREATMENT OF ADDICTION
- PCP AND HALLUCINOGENS
- AGE-SPECIFIC PATTERNS OF HALLUCINOGEN USE IN THE US POPULATION: AN ANALYSIS USING GENERALIZED ADDITIVE MODELS
- PSYCHEDELIC GENERATIONS: SIMILARITIES AND DIFFERENCES OF SOCIO-CULTURAL FACTORS RELATED TO HISTORIC & CONTEMPORARY USE OF LSD AND OTHER HALLUCINOGENIC DRUGS. EN: OLD AND NEW POLICIES, THEORIES, RESEARCH METHODS AND DRUG USERS ACROSS EUROPE
- DO HALLUCINOGENS CAUSE RESIDUAL NEUROPSYCHOLOGICAL TOXICITY?
- Abnormal visual experiences in individuals with histories of hallucinogen use: A web based questionnaire
- ALUCINOGENOS Y DROGAS DISOCIATIVAS. INCLUYENDO LA LSD, EL PCP, LA KETAMINA Y EL DEXTROMETORFANO (EN INGLES: HALLUCINOGENS AND DISSOCIATIVES DRUGS. INCLUDING LSD, PCP, KETAMINE, DEXTROMETHORPHAN)